Search
for
Sort by
Research 451–480 of 1000+
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- Epigenetics of Colorectal Cancer
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- PROTACs: A novel strategy for cancer drug discovery and development
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial
- Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time
- Amphiregulin in Fibrotic Diseases and Cancer
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
- Amphiregulin in Fibrotic Diseases and Cancer
- Eyelash trichomegaly complicating pembrolizumab for colorectal cancer
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Estrogens and aging skin
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Resident macrophages of the lung and liver: The guardians of our tissues
- Ottawa, Ontario, Canada, February 13–16, 2013
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Usefulness of Dermoscopy to Provide Accurate Assessment of Skin Cancers
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- EMT Factors and Metabolic Pathways in Cancer
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development
- β‐Sitosterol—Dietary sources and role in cancer and diabetes management
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models